Product Name

  • Name

    Acetylcholine chloride

  • EINECS 200-468-8
  • CAS No. 60-31-1
  • Article Data12
  • CAS DataBase
  • Density 1.1235 (rough estimate)
  • Solubility soluble in cold water
  • Melting Point 146-150 °C(lit.)
  • Formula C7H16NO2.Cl
  • Boiling Point
  • Molecular Weight 181.663
  • Flash Point
  • Transport Information
  • Appearance White crystalline powder
  • Safety 26-37/39-36
  • Risk Codes 36/37/38
  • Molecular Structure Molecular Structure of 60-31-1 (Acetylcholine chloride)
  • Hazard Symbols IrritantXi
  • Synonyms Cholineacetate (ester), chloride (8CI);Ethanaminium, 2-(acetyloxy)-N,N,N-trimethyl-,chloride (9CI);(2-Hydroxyethyl)trimethylammonium chloride acetate;2-Acetoxyethyltrimethylammonium chloride;ACh chloride;Acecholin;Acecoline;Acetylcholinium chloride;Arterocoline;Miochol;O-Acetylcholine chloride;Ovisot;Trimethyl(2-acetoxyethyl)ammonium chloride;
  • PSA 26.30000
  • LogP -2.74030

Synthetic route

choline chloride
67-48-1

choline chloride

acetic anhydride
108-24-7

acetic anhydride

acetylcholine chloride
60-31-1

acetylcholine chloride

choline chloride
67-48-1

choline chloride

acetyl chloride
75-36-5

acetyl chloride

acetylcholine chloride
60-31-1

acetylcholine chloride

trimethylamine
75-50-3

trimethylamine

<β-chloro-ethyl>-acetate

<β-chloro-ethyl>-acetate

acetylcholine chloride
60-31-1

acetylcholine chloride

Conditions
ConditionsYield
With benzene
choline chloride
67-48-1

choline chloride

acetic acid
64-19-7

acetic acid

A

acetylcholine chloride
60-31-1

acetylcholine chloride

B

H2O

H2O

Conditions
ConditionsYield
With macrocyclic polyphenolate at 60℃; Equilibrium constant; pH 10.0; ionic strength 0.10 M; var. pH;
C29H38N6O4*C7H16NO2(1+)*Cl(1-)

C29H38N6O4*C7H16NO2(1+)*Cl(1-)

A

acetylcholine chloride
60-31-1

acetylcholine chloride

B

Trp-Aib-Gly-Leu-NHPh
232279-44-6

Trp-Aib-Gly-Leu-NHPh

Conditions
ConditionsYield
In chloroform-d1 at 24.84℃; Equilibrium constant; complex formation;
C31H42N6O4*C7H16NO2(1+)*Cl(1-)

C31H42N6O4*C7H16NO2(1+)*Cl(1-)

A

acetylcholine chloride
60-31-1

acetylcholine chloride

B

Trp-Aib-Gly-Leu-NH-C6H3(3,5-Me2)
271770-12-8

Trp-Aib-Gly-Leu-NH-C6H3(3,5-Me2)

Conditions
ConditionsYield
In chloroform-d1 at 24.84℃; Equilibrium constant; complex formation;
C32H32O4*C7H16NO2(1+)*Cl(1-)

C32H32O4*C7H16NO2(1+)*Cl(1-)

A

acetylcholine chloride
60-31-1

acetylcholine chloride

B

2,11,20,29-tetraoxa[3.3.3.3]paracyclophane
143760-37-6

2,11,20,29-tetraoxa[3.3.3.3]paracyclophane

Conditions
ConditionsYield
In chloroform-d1 at 22.85℃; Equilibrium constant;
C7H16NO2(1+)*C33H32N4O6*Cl(1-)

C7H16NO2(1+)*C33H32N4O6*Cl(1-)

A

N-[N-(3-carboxypropanoyl)-tryptophyl]-1-benzyltryptophan

N-[N-(3-carboxypropanoyl)-tryptophyl]-1-benzyltryptophan

B

acetylcholine chloride
60-31-1

acetylcholine chloride

Conditions
ConditionsYield
In water-d2 pH=7.4; Equilibrium constant; aq. buffer;
C7H16NO2(1+)*C40H38N4O6*Cl(1-)

C7H16NO2(1+)*C40H38N4O6*Cl(1-)

A

N-[N-(3-carboxypropanoyl)-1-benzyltryptophyl]-1-benzyltryptophan

N-[N-(3-carboxypropanoyl)-1-benzyltryptophyl]-1-benzyltryptophan

B

acetylcholine chloride
60-31-1

acetylcholine chloride

Conditions
ConditionsYield
In water-d2 pH=7.4; Equilibrium constant; aq. buffer;
C7H16NO2(1+)*C23H24N2O5*Cl(1-)

C7H16NO2(1+)*C23H24N2O5*Cl(1-)

A

N-(3-carboxypropanoyl)-1-benzyltryptophan

N-(3-carboxypropanoyl)-1-benzyltryptophan

B

acetylcholine chloride
60-31-1

acetylcholine chloride

Conditions
ConditionsYield
In water-d2 pH=7.4; Equilibrium constant; aq. buffer;
C7H16NO2(1+)*C28H32N4O5*Cl(1-)
852998-99-3

C7H16NO2(1+)*C28H32N4O5*Cl(1-)

A

acetylcholine chloride
60-31-1

acetylcholine chloride

B

(S,S)-methyl 2-[2-tert-butoxycarbonylamino-3-(indol-3-yl)-propionylamino]-3-(indol-3-yl)propanoate
72254-56-9

(S,S)-methyl 2-[2-tert-butoxycarbonylamino-3-(indol-3-yl)-propionylamino]-3-(indol-3-yl)propanoate

Conditions
ConditionsYield
In chloroform-d1 Equilibrium constant;
C7H16NO2(1+)*C35H38N4O5*Cl(1-)

C7H16NO2(1+)*C35H38N4O5*Cl(1-)

A

methyl N-[N-(tert-butoxycarbonyltryptophyl)]-1-benzyltryptophanate
1256796-96-9

methyl N-[N-(tert-butoxycarbonyltryptophyl)]-1-benzyltryptophanate

B

acetylcholine chloride
60-31-1

acetylcholine chloride

Conditions
ConditionsYield
In chloroform-d1 Equilibrium constant;
C7H16NO2(1+)*C42H44N4O5*Cl(1-)

C7H16NO2(1+)*C42H44N4O5*Cl(1-)

A

methyl N-[N-(tert-butoxycarbonyl)-1-benzyltryptophyl]-1-benzyltryptophanate
1256796-97-0

methyl N-[N-(tert-butoxycarbonyl)-1-benzyltryptophyl]-1-benzyltryptophanate

B

acetylcholine chloride
60-31-1

acetylcholine chloride

Conditions
ConditionsYield
In chloroform-d1 Equilibrium constant;
acetylcholine chloride
60-31-1

acetylcholine chloride

acetylcholine gibberallate

acetylcholine gibberallate

Conditions
ConditionsYield
In methanol at 25℃; for 0.5h;97%
acetylcholine chloride
60-31-1

acetylcholine chloride

sodium tetrakis[(3,5-di-trifluoromethyl)phenyl]borate
79060-88-1

sodium tetrakis[(3,5-di-trifluoromethyl)phenyl]borate

2-acetyloxy-N,N,N-trimethylethanaminium tetrakis[3,5-bis(trifluoromethyl)phenyl]borate

2-acetyloxy-N,N,N-trimethylethanaminium tetrakis[3,5-bis(trifluoromethyl)phenyl]borate

Conditions
ConditionsYield
In methanol at 20℃; for 4h;90%
sodium 1,2,3,4-tetracyano-5-((1R,3R,4S)-menthoxycarbonyl)cyclopentadienide

sodium 1,2,3,4-tetracyano-5-((1R,3R,4S)-menthoxycarbonyl)cyclopentadienide

acetylcholine chloride
60-31-1

acetylcholine chloride

C7H16NO2(1+)*C20H19N4O2(1-)

C7H16NO2(1+)*C20H19N4O2(1-)

Conditions
ConditionsYield
In water Inert atmosphere;88%
sodium 1,2,3,4-tetracyano-5-phenylcyclopentadienide

sodium 1,2,3,4-tetracyano-5-phenylcyclopentadienide

acetylcholine chloride
60-31-1

acetylcholine chloride

C7H16NO2(1+)*C15H5N4(1-)

C7H16NO2(1+)*C15H5N4(1-)

Conditions
ConditionsYield
In water Inert atmosphere;78%
pentacyanocyclopentadienyl anion sodium salt

pentacyanocyclopentadienyl anion sodium salt

acetylcholine chloride
60-31-1

acetylcholine chloride

C7H16NO2(1+)*C10N5(1-)

C7H16NO2(1+)*C10N5(1-)

Conditions
ConditionsYield
In water Inert atmosphere;73%
sodium 1,2,3,4-tetracyano-5-(ethoxycarbonyl)cyclopentadienide

sodium 1,2,3,4-tetracyano-5-(ethoxycarbonyl)cyclopentadienide

acetylcholine chloride
60-31-1

acetylcholine chloride

C7H16NO2(1+)*C12H5N4O2(1-)

C7H16NO2(1+)*C12H5N4O2(1-)

Conditions
ConditionsYield
In water Inert atmosphere;60%
indium(III) nitrate hydrate

indium(III) nitrate hydrate

acetylcholine chloride
60-31-1

acetylcholine chloride

oxalic acid
144-62-7

oxalic acid

2C2O4(2-)*In(3+)*C7H16NO2(1+)

2C2O4(2-)*In(3+)*C7H16NO2(1+)

Conditions
ConditionsYield
In ethanol; water at 120℃; for 120h;56.8%
ethanol
64-17-5

ethanol

acetylcholine chloride
60-31-1

acetylcholine chloride

choline chloride
67-48-1

choline chloride

Conditions
ConditionsYield
beim Umkrystallisieren;
acetylcholine chloride
60-31-1

acetylcholine chloride

A

choline chloride
67-48-1

choline chloride

B

acetic acid
64-19-7

acetic acid

Conditions
ConditionsYield
With macrocyclic polyphenolate; water at 60℃; Rate constant; Equilibrium constant; Mechanism; pH 10.0; ionic strength 0.10 M; var. pH;
acetylcholine chloride
60-31-1

acetylcholine chloride

Trp-Aib-Gly-Leu-NHPh
232279-44-6

Trp-Aib-Gly-Leu-NHPh

C29H38N6O4*C7H16NO2(1+)*Cl(1-)

C29H38N6O4*C7H16NO2(1+)*Cl(1-)

Conditions
ConditionsYield
In chloroform-d1 at 24.84℃; Equilibrium constant; complex formation;
acetylcholine chloride
60-31-1

acetylcholine chloride

Trp-Aib-Gly-Leu-NH-C6H3(3,5-Me2)
271770-12-8

Trp-Aib-Gly-Leu-NH-C6H3(3,5-Me2)

C31H42N6O4*C7H16NO2(1+)*Cl(1-)

C31H42N6O4*C7H16NO2(1+)*Cl(1-)

Conditions
ConditionsYield
In chloroform-d1 at 24.84℃; Equilibrium constant; complex formation;
acetylcholine chloride
60-31-1

acetylcholine chloride

2,11,20,29-tetraoxa[3.3.3.3]paracyclophane
143760-37-6

2,11,20,29-tetraoxa[3.3.3.3]paracyclophane

C32H32O4*C7H16NO2(1+)*Cl(1-)

C32H32O4*C7H16NO2(1+)*Cl(1-)

Conditions
ConditionsYield
In chloroform-d1 at 22.85℃; Equilibrium constant; Thermodynamic data; Further Variations:; Reaction partners;
acetylcholine chloride
60-31-1

acetylcholine chloride

hexacyclohexanocucurbit[6]uril
868751-94-4, 406498-91-7

hexacyclohexanocucurbit[6]uril

C7H16NO2(1+)*C60H72N24O12*Cl(1-)
485368-99-8

C7H16NO2(1+)*C60H72N24O12*Cl(1-)

acetylcholine chloride
60-31-1

acetylcholine chloride

tin(ll) chloride

tin(ll) chloride

2Sn(2+)*(CH3)3NC2H4OC(O)CH3(1+)*5Cl(1-)=[CH3(O)COC2H4N(CH3)3]Sn2Cl5

2Sn(2+)*(CH3)3NC2H4OC(O)CH3(1+)*5Cl(1-)=[CH3(O)COC2H4N(CH3)3]Sn2Cl5

Conditions
ConditionsYield
In neat (no solvent) heated ammonium salt and SnCl2 (1:2 molar ratio) to ca. 150°C in air; dried at 100°C overnight;
acetylcholine chloride
60-31-1

acetylcholine chloride

tin(ll) chloride

tin(ll) chloride

zinc(II) chloride
7646-85-7

zinc(II) chloride

Sn(2+)*Zn(2+)*(CH3)3NC2H4OH(1+)*5Cl(1-)=[HOC2H4N(CH3)3]ZnSnCl5

Sn(2+)*Zn(2+)*(CH3)3NC2H4OH(1+)*5Cl(1-)=[HOC2H4N(CH3)3]ZnSnCl5

Conditions
ConditionsYield
In neat (no solvent) heated ammonium salt and metal chloride (1:1:1 molar ratio) to ca. 150°C in air; dried at 100°C overnight; MAS;
acetylcholine chloride
60-31-1

acetylcholine chloride

zinc(II) chloride
7646-85-7

zinc(II) chloride

2Zn(2+)*(CH3)3NC2H4OC(O)CH3(1+)*5Cl(1-)=[CH3(O)COC2H4N(CH3)3]Zn2Cl5

2Zn(2+)*(CH3)3NC2H4OC(O)CH3(1+)*5Cl(1-)=[CH3(O)COC2H4N(CH3)3]Zn2Cl5

Conditions
ConditionsYield
In neat (no solvent) heated ammonium salt and zinc chloride (1:2 molar ratio) to ca. 150°C in air; dried at 100°C overnight;
Cu(2+)*NH2CH(CH2C6H5)CO2(1-)*C12H8N2*NO3(1-)*2H2O=[Cu(NH2CH(CH2C6H5)CO2)(C12H8N2)(H2O)]NO3*H2O

Cu(2+)*NH2CH(CH2C6H5)CO2(1-)*C12H8N2*NO3(1-)*2H2O=[Cu(NH2CH(CH2C6H5)CO2)(C12H8N2)(H2O)]NO3*H2O

acetylcholine chloride
60-31-1

acetylcholine chloride

Cu(NH2CH(CH2C6H5)CO2)(C12H8N2)Cl*3H2O

Cu(NH2CH(CH2C6H5)CO2)(C12H8N2)Cl*3H2O

Conditions
ConditionsYield
In water crystn. (room temp.), recrystn. (aq. MeOH);
C16H14N4*C42H42N28O14

C16H14N4*C42H42N28O14

acetylcholine chloride
60-31-1

acetylcholine chloride

A

4-(4-aminophenylazo)naphthalen-1-amine
1095097-66-7

4-(4-aminophenylazo)naphthalen-1-amine

B

C7H16NO2(1+)*C42H42N28O14*Cl(1-)

C7H16NO2(1+)*C42H42N28O14*Cl(1-)

Conditions
ConditionsYield
pH=4.76; aq. acetate buffer;
sodium {[3-(5,6-dihydro-1,4,2-dioxazin-3-yl)pyridin-2-yl]sulfonyl}[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]azanide

sodium {[3-(5,6-dihydro-1,4,2-dioxazin-3-yl)pyridin-2-yl]sulfonyl}[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]azanide

acetylcholine chloride
60-31-1

acetylcholine chloride

2-(acetyloxy)-N,N,N-trimethylethanaminium {[3-(5,6-dihydro-1,4,2-dioxazin-3-yl)pyridin-2-yl]sulfonyl}[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]azanide
1187432-15-0

2-(acetyloxy)-N,N,N-trimethylethanaminium {[3-(5,6-dihydro-1,4,2-dioxazin-3-yl)pyridin-2-yl]sulfonyl}[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]azanide

Conditions
ConditionsYield
In methanol; water at 20℃; for 16h;

Acetylcholine chloride Consensus Reports

Reported in EPA TSCA Inventory.

Acetylcholine chloride Specification

The IUPAC name of 2-Acetoxyethyltrimethylammonium chloride is 2-acetyloxyethyl(trimethyl)azanium chloride. With the CAS registry number 60-31-1, it is also named as Chloroacetylcholine. The product's categories are Ammonium Chlorides (Quaternary); Quaternary Ammonium Compounds. It is white crystalline powder which is easily soluble in water, ethanol and propylene glycol, soluble in chloroform and acetic acid, insoluble in ether. And it is easy to decompose in hot water and alkaline solution. When heated to decomposition it emits very toxic fumes of NOx and Cl. Additionally, this chemical should be stored in the dry place and avoided direct sunshine with the temperature of 4°C.

The other characteristics of this product can be summarized as: (1)ACD/LogP: -3.90; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): -3.9; (4)ACD/LogD (pH 7.4): -3.9; (5)ACD/BCF (pH 5.5): 1; (6)ACD/BCF (pH 7.4): 1; (7)ACD/KOC (pH 5.5): 1; (8)ACD/KOC (pH 7.4): 1; (9)#H bond acceptors: 3; (10)#H bond donors: 0; (11)#Freely Rotating Bonds: 4; (12)Rotatable Bond Count: 4; (13)Exact Mass: 181.086956; (14)MonoIsotopic Mass: 181.086956; (15)Topological Polar Surface Area: 26.3; (16)Heavy Atom Count: 11; (17)Complexity: 115.

Preparation and Uses of 2-Acetoxyethyltrimethylammonium chloride: Using chloroethanol and trimethylamine aqueous solution as the starting material. And then acylating by acetic anhydride. Finally, after refining, we can get the product. Besides, this chemical is used as substrate for determination of acetylcholinesterase.

When you are using this chemical, please be cautious about it as the following:
It is irritating to eyes, respiratory system and skin. In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. If you want to contact this product, you must wear suitable protective clothing, gloves and eye/face protection.

People can use the following data to convert to the molecule structure. 
1. SMILES:[Cl-].O=C(OCC[N+](C)(C)C)C
2. InChI:InChI=1/C7H16NO2.ClH/c1-7(9)10-6-5-8(2,3)4;/h5-6H2,1-4H3;1H/q+1;/p-1
3. InChIKey:JUGOREOARAHOCO-REWHXWOFAJ

The following are the toxicity data which has been tested.

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
frog LDLo parenteral 200mg/kg (200mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: STIFFNESS

CARDIAC: OTHER CHANGES
Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 166, Pg. 437, 1932.
frog LDLo unreported 500mg/kg (500mg/kg) PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)
Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 164, Pg. 346, 1932.
guinea pig LD50 intravenous 7700ug/kg (7.7mg/kg)   Archives Internationales de Pharmacodynamie et de Therapie. Vol. 170, Pg. 461, 1967.
mouse LD50 intraperitoneal 15300ug/kg (15.3mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
Farmakologiya i Toksikologiya Vol. 20(4), Pg. 32, 1957.
mouse LD50 intravenous 10mg/kg (10mg/kg) PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE Journal of Pharmacology and Experimental Therapeutics. Vol. 119, Pg. 541, 1957.
 
mouse LD50 oral 3gm/kg (3000mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 58, Pg. 337, 1936.
mouse LD50 subcutaneous 170mg/kg (170mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 58, Pg. 337, 1936.
rat LD50 intravenous 22mg/kg (22mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 58, Pg. 337, 1936.
rat LD50 oral 2500mg/kg (2500mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 58, Pg. 337, 1936.
rat LD50 subcutaneous 250mg/kg (250mg/kg)   Journal of Pharmacology and Experimental Therapeutics. Vol. 58, Pg. 337, 1936.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View